Table 3. Lenvatinib-related adverse events.
Adverse event | All grades, n (%) | Grade 3, n (%) | Grade 4, n (%) |
---|---|---|---|
Hypertension | 4 (33.3) | 1 (8.3) | 0 |
Fatigue | 1 (8.3) | 0 | 0 |
Myalgia | 1 (8.3) | 0 | 0 |
Hand-foot skin reaction | 1 (8.3) | 0 | 0 |
Rush | 1 (8.3) | 0 | 0 |
Decreased appetite | 1 (8.3) | 0 | 0 |
Decreased platelet | 1 (8.3) | 0 | 0 |
Diarrhea | 1 (8.3) | 0 | 0 |
Edema | 1 (8.3) | 0 | 0 |